| A Phase II, Controlled Clinical Study Designed to Evaluate the Effect of ArtemiC in Patients Diagnosed With COVID-19 (NCT04382040) | MGC Pharmaceuticals d.o.o | 2020-05-08 |
| Early CPAP in COVID-19 Confirmed or Suspected Patients (NCT04390191) | Icahn School of Medicine at Mount Sinai | 2020-05-07 |
| ROCO - Self-help for People With Psychological Distress Due to the Covid-19 Situation (NCT04380909) | University of Bern | 2020-05-06 |
| A Study of COVID 19 Convalescent Plasma in High Risk Patients With COVID 19 Infection (NCT04392232) | TriHealth Inc. | 2020-05-05 |
| Convalescent Plasma for Patients With COVID-19 (NCT04385199) | Henry Ford Health System | 2020-05-04 |
| Convalescent Plasma for Patients With COVID-19: A Pilot Study (NCT04332380) | Universidad del Rosario | 2020-05-01 |
| Does Hydroxychloroquine Before & During Patient Exposure Protect Healthcare Workers From Coronavirus? (NCT04374942) | Megan Landes | 2020-04-30 |
| Plasma Exchange in Patients With COVID-19 Disease and Invasive Mechanical Ventilation: a Randomized Controlled Trial (NCT04374539) | Fundacion Clinic per a la Recerca Biomédica | 2020-04-29 |
| Chloroquine/ Hydroxychloroquine Prevention of Coronavirus Disease (COVID-19) in the Healthcare Setting (NCT04303507) | University of Oxford | 2020-04-29 |
| Passive Immunity Trial for Our Nation to Treat COVID-19 in Hospitalized Adults (NCT04362176) | Vanderbilt University Medical Center | 2020-04-24 |
| Sevoflurane in COVID-19 ARDS (SevCov) (NCT04355962) | University of Zurich | 2020-04-23 |
| St. Jude Tracking of Viral and Host Factors Associated With COVID-19 (NCT04362995) | St. Jude Children's Research Hospital | 2020-04-23 |
| Prognostic Value of Point of Care Cardiac and Lung Ultrasound in COVID-19 (NCT04379544) | University of Pennsylvania | 2020-04-23 |
| Evaluation of Antibody Tests for COVID-19 (NCT04360954) | Washington University School of Medicine | 2020-04-23 |
| A Study of a Candidate COVID-19 Vaccine (COV001) (NCT04324606) | University of Oxford | 2020-04-23 |
| Anti-Coronavirus Therapies to Prevent Progression of Coronavirus Disease 2019 (COVID-19) Trial (NCT04324463) | Population Health Research Institute | 2020-04-21 |
| ACCESS A Master Digital Surveillance Protocol for COVID-19 (NCT04363268) | Medable Inc. | 2020-04-20 |
| Closed-Loop Oxygen to Verify That Healthcare Workers Interventions Decrease During SARS-CoV-2 Pneumonia (COVID-19) (NCT04320056) | Laval University | 2020-04-20 |
| BCG Vaccine for Health Care Workers as Defense Against COVID 19 (NCT04348370) | Texas A&M University | 2020-04-20 |
| ASCO Survey on COVID-19 in Oncology (ASCO) Registry (NCT04659135) | American Society of Clinical Oncology | 2020-04-19 |
| ARMOR Study: COVID-19 Seroprevalence Among Healthcare Workers (NCT04367857) | Columbia University | 2020-04-18 |
| CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients (NCT04364737) | NYU Langone Health | 2020-04-17 |
| A Study to Explore the Role of Gut Flora in COVID-19 Infection (NCT04359836) | ProgenaBiome | 2020-04-16 |
| COVID-19 Diagnostic Self-testing Using Virtual Point-of-care (NCT04348864) | Neuroganics LLC | 2020-04-16 |
| Efficacy of Chloroquine or Hydroxychloroquine in Treating Pneumonia Caused by SARS-Cov-2 - COVID-19 (NCT04420247) | Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva | 2020-04-16 |
| Convalescent Plasma Collection and Treatment in Pediatrics and Adults (NCT04376034) | West Virginia University | 2020-04-16 |
| COvid-19 and Vitamin D Supplementation: a Multicenter Randomized Controlled Trial of High Dose Versus Standard Dose Vitamin D3 in High-risk COVID-19 Patients (CoVitTrial) (NCT04344041) | University Hospital, Angers | 2020-04-15 |
| Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France (NCT04336761) | University Hospital, Lille | 2020-04-15 |
| COVID-19 Biorepository (NCT04568148) | University of Kansas Medical Center | 2020-04-15 |
| The McMaster Multi-Regional COVID-19 Hospital Case Registry (NCT04508959) | McMaster University | 2020-04-15 |
| Observational Study of COVID-19 Treatment Efficacy (NCT04369989) | OSF Healthcare System | 2020-04-14 |
| Place of Circulating Biomarkers and Respiratory Eicosanoids in the Prognosis of Severe Forms of Covid-19 Pneumonia (NCT04485364) | Fondation Hôpital Saint-Joseph | 2020-04-14 |
| An Observational Study of Patients With Coronavirus Disease 2019 (NCT04331886) | Target PharmaSolutions, Inc. | 2020-04-13 |
| Predictive Biomarkers of Secondary Aggravation in Covid-19 Suspect Patient (NCT04341792) | University Hospital, Lille | 2020-04-11 |
| COVID-19 First In Human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of EIDD-2801 in Healthy Volunteers (NCT04392219) | Ridgeback Biotherapeutics, LP | 2020-04-10 |
| COVID-19 Convalescent Plasma (NCT04340050) | University of Chicago | 2020-04-10 |
| A Double-blind, Placebo-controlled Clinical Trial of Fluvoxamine for Symptomatic Individuals With COVID-19 Infection (NCT04342663) | Washington University School of Medicine | 2020-04-10 |
| TARGet Kids! COVID-19 Study of Children and Families (NCT04449978) | The Hospital for Sick Children | 2020-04-09 |
| Clinical Characterization Protocol for Severe Infectious Diseases (CCPSEI) (NCT04496466) | Johns Hopkins University | 2020-04-09 |
| Simple, Safe, Same: Lung Ultrasound for COVID-19 (NCT04322487) | Catholic University of the Sacred Heart | 2020-04-08 |
| COVID-19 Community Research Partnership (NCT04342884) | Wake Forest University Health Sciences | 2020-04-08 |
| Understanding Immunity to SARS-CoV-2, the Coronavirus Causing COVID-19 (NCT04373148) | Stanford University | 2020-04-08 |
| Rutgers COVID-19 Cohort Study (NCT04336215) | Rutgers, The State University of New Jersey | 2020-04-07 |
| PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine (NCT04353037) | UnitedHealth Group | 2020-04-07 |
| Will Hydroxychloroquine Impede or Prevent COVID-19 (NCT04341441) | Henry Ford Health System | 2020-04-07 |
| Evaluation of Novel Diagnostic Tests for COVID-19 (NCT04326387) | CCTU- Cancer Theme | 2020-04-06 |
| Patient Preference Trial for COVID-19 (PPT-COVID) (NCT04418193) | Centre Hospitalier Princesse Grace | 2020-04-06 |
| At-Home COVID-19 Antibody Test Usability Assessment & Behavior Change Study (NCT04393961) | ProofPilot | 2020-04-05 |
| Acceptance and Commitment Therapy Delivered by Automated Software Messaging (NCT04329897) | University of Iowa | 2020-04-05 |
| Characteristics of TraceTogether Users (NCT04468581) | Yale-NUS College | 2020-04-03 |
| COVID-19 Pandemic Response Network (NCT04320862) | Duke University | 2020-04-03 |
| Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease (NCT04332991) | Massachusetts General Hospital | 2020-04-02 |
| Hydroxychloroquine Versus Placebo in COVID-19 Patients at Risk for Severe Disease (NCT04325893) | University Hospital, Angers | 2020-04-01 |
| Dexamethasone and COVID-19 Inpatient Mortality (NCT04926571) | Aetion, Inc. | 2020-04-01 |
| Hydroxychloroquine Treatment of Healthcare Workers With COVID19 Illness at Montefiore (NCT04350450) | Montefiore Medical Center | 2020-04-01 |
| Convalescent Plasma to Limit Coronavirus Associated Complications (NCT04325672) | Mayo Clinic | 2020-04-01 |
| Personalized Health Education Against the Health Damage of Novel Coronavirus (COVID-19) Outbreak in Hungary (NCT04321928) | University of Pecs | 2020-04-01 |
| A Human Clinical Study to Collect Calibration and Performance Data for the RBA-2 Device (NCT04357977) | Kaligia Biosciences, LLC | 2020-04-01 |
| Viral Infection and Respiratory Illness Universal Study[VIRUS]: COVID-19 Registry (NCT04323787) | Mayo Clinic | 2020-03-30 |
| Outcomes of Elective Cancer Surgery During the COVID-19 Pandemic Crisis (NCT04384926) | University of Birmingham | 2020-03-30 |
| Risk Factors for Community- and Workplace Transmission of COVID-19 (NCT04320732) | Oslo University Hospital | 2020-03-27 |
| Telephony Or Videophony for Isolated elDerly in Maine-Et-Loire 49 During COVID-19 (NCT04333849) | University Hospital, Angers | 2020-03-25 |
| Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP Canada) (NCT04421664) | McGill University Health Centre/Research Institute of the McGill University Health Centre | 2020-03-25 |
| Biomarkers for Identification of COVID-19 Infection (NCT04322513) | University of Catanzaro | 2020-03-24 |
| Respiratory Decompensation and Model for the Triage of COVID-19 Patients (NCT04390516) | Dascena | 2020-03-24 |
| Nitric Oxide Gas Inhalation in Severe Acute Respiratory Syndrome in COVID-19 (NCT04306393) | Massachusetts General Hospital | 2020-03-21 |
| Behavior, Environment And Treatments for Covid-19 (NCT04321811) | xCures | 2020-03-21 |
| COVID-19 PRIORITY (Pregnancy CoRonavIrus Outcomes RegIsTrY) (NCT04323839) | University of California, San Francisco | 2020-03-20 |
| Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 (NCT04308668) | University of Minnesota | 2020-03-17 |
| Adverse Events Related to Treatments Used Against Coronavirus Disease 2019 (NCT04314817) | Groupe Hospitalier Pitie-Salpetriere | 2020-03-17 |
| Covid-19 and Vitamin D in Nursing-home (NCT04435119) | University Hospital, Angers | 2020-03-15 |
| Hemodynamic Characteristics of Patients With SARS-CoV-2 (NCT04337983) | Bicetre Hospital | 2020-03-13 |
| Identification of a Responsive Subpopulation to Hydroxychloroquine in COVID-19 Patients Using Machine Learning (NCT04423991) | Dascena | 2020-03-10 |
| "COVID-19 and Diabetes Outcomes" (NCT04324736) | Nantes University Hospital | 2020-03-10 |
| Factors Associated With a Positive SARS-CoV-2 Serology in Contact Subjects at High/Moderate Risk of Coronavirus SARS-CoV-2 Infection. COVID-19. (NCT04322279) | Institut National de la Santé Et de la Recherche Médicale, France | 2020-03-09 |
| Social Media Use During COVID-19 (NCT04305574) | Jean Liu | 2020-03-07 |
| Darunavir/Cobicistat vs. Lopinavir/Ritonavir in COVID-19 Pneumonia in Qatar (NCT04425382) | Hamad Medical Corporation | 2020-03-01 |
| Medical Masks vs N95 Respirators for COVID-19 (NCT04296643) | McMaster University | 2020-03-01 |
| COVID-19 Risk Stratification (NCT04339387) | Brigham and Women's Hospital | 2020-03-01 |
| A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia (NCT04276987) | Ruijin Hospital | 2020-02-15 |
| Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19 (NCT04261517) | Shanghai Public Health Clinical Center | 2020-02-06 |
| Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19. (NCT04259892) | Institut National de la Santé Et de la Recherche Médicale, France | 2020-02-04 |
| Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19 (NCT04292340) | Shanghai Public Health Clinical Center | 2020-02-01 |
| Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (NCT04328454) | Shanghai 10th People's Hospital | 2020-01-30 |
| Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19 (NCT04252274) | Shanghai Public Health Clinical Center | 2020-01-30 |
| Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection (NCT04279782) | Third Affiliated Hospital, Sun Yat-Sen University | 2020-01-20 |
| Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations (NCT04279795) | Third Affiliated Hospital, Sun Yat-Sen University | 2020-01-20 |
| Outcomes of Surgery in COVID-19 Infection: International Cohort Study (CovidSurg) (NCT04323644) | University of Birmingham | 2020-01-01 |
| Clinical and Radiomic Model of COVID-19 (NCT04337502) | Maastricht University | 2019-12-23 |
| Perceived Stress Among ICU Medical Staff During COVID-19 Crisis (NCT04604769) | University of Liege | 2019-06-26 |
| Outcomes Mandate National Integration With Cannabis as Medicine (NCT03944447) | OMNI Medical Services, LLC | 2018-12-01 |
| Lessening Organ Dysfunction With VITamin C (NCT03680274) | Université de Sherbrooke | 2018-11-08 |
| The Respiratory Protection Effectiveness Clinical Trial (NCT01249625) | Johns Hopkins University | 2010-12-01 |
| Eculizumab (Soliris) in Covid-19 Infected Patients (NCT04288713) | Hudson Medical | |